Left Ventricular Assist Device and Exercise

Size: px
Start display at page:

Download "Left Ventricular Assist Device and Exercise"

Transcription

1 Left Ventricular Assist Device and Exercise Marie Christine Iliou Réadaptation cardiaque et prévention secondaire Hôpital Corentin Celton- HUPO Issy les Moulineaux

2 Déclaration de Relations Professionnelles Disclosure Statement of Financial Interest J'ai actuellement, ou j'ai eu au cours des deux dernières années, une affiliation ou des intérêts financiers ou intérêts de tout ordre avec une société commerciale ou je reçois une rémunération ou des redevances ou des octrois de recherche d'une société commerciale : I currently have, or have had over the last two years, an affiliation or financial interests or interests of any order with a company or I receive compensation or fees or research grants with a commercial company : Affiliation/Financial Relationship Grant/Research Support Consulting Fees/Honoraria Major Stock Shareholder/Equity Royalty Income Ownership/Founder Intellectual Property Rights Other Financial Benefit Company ResMed Servier, Astra Zenezca None None None None None

3 Indications Trochu JN. Arch Cardiovasc Dis 2012;105:114-21

4 Left Ventricular Assist Devices Bridge or Destination therapy

5 Cardio-vascular adaptations to exercise Healthy HF LVAD HR Chronotropic insufficiency Chronotropic insufficiency Preload preload and filling pressure preload and filling pressure Afterload Contractility Impaired depending on LV function Systemic vasc resist Cardiac Output Inability to But not normal

6 Other adaptations to exercise Respiratory rate VE Healthy HF LVAD Improvements in ventilatory efficiency and respiratory strengh Muscular fibers Use type I fibers > II Atrophy, wasting Switch type I-> II mitochondrial density unknown Endothelium and muscle flow Endothelial dysfunction oxygen diffusion to muscle Improvement of endoth function and muscle flow. But peripheral vascular function is compromised by the no-pulsatility Sympathetic function with para withdrawal Overstimulation Improvement of baroreflex activity (at rest)

7 Physiology exercise with LVAD Loyaga-Rendon R. J Heart Lung Transplant 2015;34:

8 Physiology exercise with LVAD Opening Ao valve % VO2 without increase in CO Loyaga-Rendon R. J Heart Lung Transplant 2015;34:

9 Factors of exercise intolerance in LVAD pts Type of LVAD (PF vs CF): Speed in CF LVAD: Native contractility: Time after implantation: RV dysfunction: Pulmonary function: Peripheral factors: Minimal or no effect on peak VO2 Low increase peak VO2 due to increased O 2 extraction Important contribution to excercise capacity Maximal improvements on peak VO2 at 3 months Studies suggest that RV function may be not limiting ex capacity, but require further evaluation Continued impairements in respiratory muscles and ventilationperfusion coupling are more important limitation than pulmonary vasc resistance Limited investigations have focused on musculo-skeletal function, anemia, and endothelial dysfunction Loyaga-Rendon R. J Heart Lung Transplant 2015;34:

10 Exercise capacity HF vs LVAD Mancini D, Circulation 1998;98:1178

11 Exercise capacity with LVAD Author n Findings Burrell (2015) 48 Invasive exercise hemodynamic testing : - Exercise is associated with a modest increase device output and rapid Pcwp - Progressive aortic regurgitation is associated with limited ex capacity Kerrigan (2015) 24 % HR reserve is a good predictor of % VO2 reserve in non paced patients (in these RPE is a suitable surrogate measure) Benton (2015) 37 Peak VO2 at 6 months reached 14,7 ml/kg/min (51 % of predicted)

12 Long term effects 67 patients LVEF LV EDD Maybaum S. Circulation 2007;115:

13 Symptoms LV Dysfunction Peripheral modifications

14 Heart Failure Class Level LVEF < 40 % - Global management - Long term programmes I A - Patient Education - Treatment adjustements Preserved LVEF - Improvement of QOL - Reduction of hospitalisations II b C CRT - mamimize effects of CRT - Evaluation of resynchronization I B LVAD - Physical reconditionning - Patient Education : device and anticoagulants IIa C Transplantation - Pre-transplantation - Specific after surgery, physiology and immunology I B - Psycho-social support

15 Exercise training in LVAD 15 patients (10 ExT et 5 Control), 37 ± 17 years Training : home-based bike or treadmill 45 min (Borg 12-14), 3 à 5/week + inspiratory muscle trainin 2-3/week 10 weeks + 15 % Laoutaris I. Eur J Cardiovasc Prev Rehab 2011;18:33-40

16 Ex Training Control Ex Training group Peak VO % * VT % * VE/VCO2-10 % * 6 WT + 14 % * Pi max (insp P 1 ) + 38 %* Spi max (insp P max) + 42 % *

17 Exercise training Study year n age type duration Peak VO 2 Training Laoutaris /5 40 LVAD, BiVAD 10 weeks + 15 % 45, 3-5/week endurance + Insp muscle Hayes /7 46 VentrAssist 8 weeks + 29 % 60 3/week Continuous T + resistance Kugler /36 52 HeartMate II, Heartware 18 months + 13 % Home + psychosocial + nutrition Compostella Jarvik, Berlin 2 weeks Id IC 6 /week Endurance, gym, respiratory T Kaparolat Berlin, HM II 8 weeks + 3 % 90 3/sem Endurance, gym, respiratory T Alsara HM II, VA, DuraHeart 1 week Autonomy scores improvement Marko LVAD 4,5 weeks + 28 % Endurance, walking, strenght

18 Predictors of weaning from LVAD?? CPET, a tool for myocardial recovery prediction?? Peak VO2 indepent of the pump speed can be used as an indicator for myocardial recovery (30 patients : 20 explanted vs 10 transplanted, Noor) sbp response to exercise (reach > 120 mmhg) provides sufficient CV reserve to tolerate weaning (106 pts, 38 explanted, Fukumitsu) Recently a novel scoring (33 pts pulsatile, 45 continuous flow) RV function? Imamura T. Circ J 2015;79: 560-6

19 Exercise training for LVAD in Europe 77 LVAD implanting centers : 45 have Ex T program 71 % early post-discharge, 24 % offer a long-term maintenance program Professionals Physiotherapists 73 % Nurses, psychologists 22 % Cardiologist specilaized in CR 22 % Training programs Endurance : 84 % Resistance : 47 % Respiratory muscle training : 55 % Ben Gal T, Int J Cardiol 2015;201:215-19

20 French registry (preliminary results) 7 centers 66 patients (54 males), 56 ± 11 years CR referral : 100 days (21-553) post VAD implant Indications : 65.5 % ischemic CM, 22.3 % DCM 72 % had CPx Exercise training : 24 sessions as mean No adverse event Kubas S on behalf to GERS

21 TAH vs LVAD Kholi H. J Heart Lung Transplant 2011;30:

22 Total Artificial Heart Mr P S, 50 years ans 71 kg 1m70 Peak Pic VO2 VO2 = = ml/kg/min, ml/kg/min, watts watts VT1 SV1 = ml/kg/min, watts Peak VO2 = 16.3 ml/kg/min, 90 watts VT1 = 12.9 ml/kg/min, 50 watts

23 Preliminary results in the «true life» 23 patients 17 men, mean age 52 years CR 71 ± 32 days after implantation 35 Ex T sessions : endurance and resistance CPET workload (watts) 52.7 ± ± 20 <0.05 Peak VO2 max (ml/kg/mn) 12.6 ± ± 4.9 <0.05 VT1 (ml/kg/mn) 10 ± ± 4 < % VE/VCO2 slope 45.5 ± 9 43 ± 8 NS 6 walking test distance(m) ± ± 90 <0.05 Iliou MC, unpublished

24 Conclusions LVAD implantation improves the exercise capacity of HF patients This improvement is limited and related with device functioning, native left and right ventricular contractility, pulmonary, muscular, vessels and nerve systems abnormalities Exercise training is these patients means a great deal for all the LVAD patients and much more for the bridge indications.

Cardiac Rehabilitation and Electromyostimulation

Cardiac Rehabilitation and Electromyostimulation CREMS-HF Cardiac Rehabilitation and Electromyostimulation Dr Marie Christine Iliou Dr Bénédicte Vergès CREMS-HF study GERS SFC Déclaration de Relations Professionnelles Disclosure Statement of Financial

More information

L essentiel de 2013 Exercice Readaptation et Sport (GERS) Dr Marie Christine Iliou

L essentiel de 2013 Exercice Readaptation et Sport (GERS) Dr Marie Christine Iliou PARIS 15-19 Janvier 2014 L essentiel de 2013 Exercice Readaptation et Sport (GERS) Dr Marie Christine Iliou Déclaration de Relations Professionnelles Disclosure Statement of Financial Interest J'ai actuellement,

More information

P. Messner Pellenc, C. Robert

P. Messner Pellenc, C. Robert P. Messner Pellenc, C. Robert Déclaration de Relations Professionnelles Disclosure Statement of Financial Interest J'ai actuellement, ou j'ai eu au cours des deux dernières années, une affiliation ou des

More information

What is controversial in diagnostic imaging?

What is controversial in diagnostic imaging? Controversies in the management of pulmonary hypertension What is controversial in diagnostic imaging? G. Derumeaux Lyon University Hospices Civils de Lyon France Déclaration de Relations Professionnelles

More information

Curtin University is a trademark of Curtin University of Technology CRICOS Provider Code 00301J

Curtin University is a trademark of Curtin University of Technology CRICOS Provider Code 00301J Exercise-based cardiac rehabilitation for people with ventricular assist devices: Associate Professor Andrew Maiorana School of Physiotherapy and Exercise Science, Curtin University; Advanced Heart Failure

More information

Paradoxical low flow-low gradient severe aortic stenosis: where are we?

Paradoxical low flow-low gradient severe aortic stenosis: where are we? Journées Européennes de la SFC Paris, 15 janvier 2016 Paradoxical low flow-low gradient severe aortic stenosis: where are we? Nicolas Mansencal Hôpital Ambroise Paré, Boulogne Centre de Réf ce pour les

More information

Cardiac Rehabilitation Program for LVAD Patients. Dr Katherine Fan Consultant Cardiologist Grantham Hospital, Hong Kong SAR

Cardiac Rehabilitation Program for LVAD Patients. Dr Katherine Fan Consultant Cardiologist Grantham Hospital, Hong Kong SAR Cardiac Rehabilitation Program for LVAD Patients Dr Katherine Fan Consultant Cardiologist Grantham Hospital, Hong Kong SAR Left Ventricular Assist Devices (LVAD) Improved Survival Following LVAD Implantations

More information

Continuous and noninvasive arterial blood pressure monitoring

Continuous and noninvasive arterial blood pressure monitoring Continuous and noninvasive arterial blood pressure monitoring Pr. Jean-Luc Fellahi fellahi-jl@chu-caen.fr Pôle Réanimations-Anesthésie-SAMU, CHU de Caen UFR de Médecine, EA4650, Université de Caen Basse-Normandie

More information

Hypertrophic Cardiomyopathy or «Athlete s Heart»

Hypertrophic Cardiomyopathy or «Athlete s Heart» Hypertrophic Cardiomyopathy or «Athlete s Heart» S. GUERARD, J-R. CAIGNAULT, V. GRIFFET Desgenettes Military Hospital LYON Déclaration de Relations Professionnelles Disclosure Statement of Financial Interest

More information

MYOCARDITIS AND BIOMARKERS. Dr C. Guenancia Service de Cardiologie CHU Dijon

MYOCARDITIS AND BIOMARKERS. Dr C. Guenancia Service de Cardiologie CHU Dijon MYOCARDITIS AND BIOMARKERS Dr C. Guenancia Service de Cardiologie CHU Dijon Déclaration de Relations Professionnelles Disclosure Statement of Financial Interest J'ʹai actuellement, ou j'ʹai eu au cours

More information

Mitral valve apparatus in Hypertrophic Cardiomyopathy: a specific assessment?

Mitral valve apparatus in Hypertrophic Cardiomyopathy: a specific assessment? Nancy, September 17th, 2015 Mitral valve apparatus in Hypertrophic Cardiomyopathy: a specific assessment? Inserm UMR1087 Institut du Thorax, Nantes Thierry le Tourneau Déclaration de Relations Professionnelles

More information

Echocardiography of the young athlete: Where are the limits? 24 èmes Journées Européennes de la Société Française de cardiologie janvier 2014

Echocardiography of the young athlete: Where are the limits? 24 èmes Journées Européennes de la Société Française de cardiologie janvier 2014 Echocardiography of the young athlete: Where are the limits? 24 èmes Journées Européennes de la Société Française de cardiologie 15-18 janvier 2014 Sylvain GUERARD LYON-BRON Déclaration de Relations Professionnelles

More information

Insuffisance mitrale

Insuffisance mitrale Imagerie Multimodalité dans les Valvulopathies: De quoi avons nous besoin? Insuffisance mitrale Agnès Pasquet, MD, PhD Pôle de Recherche Cardiovasculaire Institut de Recherche Expérimentale et Clinique

More information

Return to Work (RTW) after Acute Coronary Syndrom (ACS) SFC

Return to Work (RTW) after Acute Coronary Syndrom (ACS) SFC + Return to Work (RTW) after Acute Coronary Syndrom (ACS) SFC - 2016 No Conflict of interest for this subject Dany Michel Marcadet Paris Déclaration de Relations Professionnelles Disclosure Statement of

More information

What is established? Risk of Benefit complica comp tion

What is established? Risk of Benefit complica comp tion What s new in exercise training in CHF? Jean-Paul Schmid, MD, FESC Consultant Cardiologist, SpitalNetzBern Tiefenau Hospital, Dept. of Internal Medicine, Cardiology, Bern, Switzerland What is established?

More information

Cancer Associated Thrombosis Approach to VTE recurrence

Cancer Associated Thrombosis Approach to VTE recurrence Cancer Associated Thrombosis Approach to VTE recurrence http://anticoag-pass-s2d.fr/ Isabelle Mahé Hôpital Louis Mourier Service de Médecine Interne APHP-Université Paris 7 EA REMES 7334-UMR 1140 France

More information

เอกราช อร ยะช ยพาณ ชย

เอกราช อร ยะช ยพาณ ชย 30 July 2016 เอกราช อร ยะช ยพาณ ชย Heart Failure and Transplant Cardiology aekarach.a@chula.ac.th Disclosure Speaker, CME service: Merck, Otsuka, Servier Consultant, non-cme service: Novartis, Menarini

More information

Ventricular Assist Devices for Permanent Therapy: Current Status and Future

Ventricular Assist Devices for Permanent Therapy: Current Status and Future Ventricular Assist Devices for Permanent Therapy: Current Status and Future Prospects Francis D. Pagani MD PhD Professor of Cardiac Surgery University of Michigan April 28 th, 2012 Disclosures NHLBI and

More information

«Which stent for which coarctation based on mechanical properties?» Modelisation

«Which stent for which coarctation based on mechanical properties?» Modelisation «Which stent for which coarctation based on mechanical properties?» Modelisation Patrice Guérin, Clément Mercier, Fabienne Jordanna L Institut du Thorax et Inserm U791 CHU Nantes JFCPC 2015 Déclaration

More information

Benefits of Combined Aerobic/Resistance/Inspiratory Muscle Training in Patients with Chronic Heart Failure. The Ideal Exercise Program for CHF?

Benefits of Combined Aerobic/Resistance/Inspiratory Muscle Training in Patients with Chronic Heart Failure. The Ideal Exercise Program for CHF? Benefits of Combined Aerobic/Resistance/Inspiratory Muscle Training in Patients with Chronic Heart Failure. The Ideal Exercise Program for CHF? I D. Laoutaris, S Adamopoulos, A Manginas, D B. Panagiotakos,

More information

The role of CPX testing in the rehabilitation of cardiac patients.

The role of CPX testing in the rehabilitation of cardiac patients. Cardiopulmonary exercise testing (CPX) for comprehensive cardiac evaluations The role of CPX testing in the rehabilitation of cardiac patients. Viviane M Conraads, MD, PhD Department of Cardiology Cardiac

More information

Medical Therapy after LVAD

Medical Therapy after LVAD Medical Therapy after LVAD Maria Frigerio 2nd Section of Cardiology, Heart Failure & Cardiac Transplant Unit DeGasperis CardioCenter, Niguarda Hospital, Milan, Italy Heart failure therapy in LVAD pts A

More information

L esercizio fisico e le patologie cardiorespiratorie: dalla valutazione funzionale alla prescrizione. M. Guazzi

L esercizio fisico e le patologie cardiorespiratorie: dalla valutazione funzionale alla prescrizione. M. Guazzi La Riabilitazione Interdisciplinare L esercizio fisico e le patologie cardiorespiratorie: dalla valutazione funzionale alla prescrizione M. Guazzi Università di Milano Dipartimento Cardiologia Universitaria

More information

VAD come Destination therapy nell adulto con Scompenso Cardiaco

VAD come Destination therapy nell adulto con Scompenso Cardiaco VAD come Destination therapy nell adulto con Scompenso Cardiaco Francesco Santini Division of Cardiac Surgery, IRCCS San Martino IST University of Genova Medical School, Italy Heart Transplantation is

More information

Modern Left Ventricular Assist Devices (LVAD) : An Intro, Complications, and Emergencies

Modern Left Ventricular Assist Devices (LVAD) : An Intro, Complications, and Emergencies Modern Left Ventricular Assist Devices (LVAD) : An Intro, Complications, and Emergencies ERIC T. ROME D.O. HEART FAILURE, MECHANICAL ASSISTANCE AND TRANSPLANTATION CVI Left Ventricular Assist Device An

More information

Ramani GV et al. Mayo Clin Proc 2010;85:180-95

Ramani GV et al. Mayo Clin Proc 2010;85:180-95 THERAPIES FOR ADVANCED HEART FAILURE: WHEN TO REFER Navin Rajagopalan, MD Assistant Professor of Medicine University of Kentucky Director, Congestive Heart Failure Medical Director of Cardiac Transplantation

More information

PHYSICAL AND SEXUAL ACTIVITIES

PHYSICAL AND SEXUAL ACTIVITIES Forgotten problems in HF PHYSICAL AND SEXUAL ACTIVITIES Massimo F Piepoli, MD, PhD, FESC, FACC Heart Failure Unit, Guglielmo da Saliceto Hospital, Piacenza m.piepoli@alice.it No disclosures Massimo Speaker

More information

Cardiopulmonary exercise test among children with congenital heart diseases: a multicenter study

Cardiopulmonary exercise test among children with congenital heart diseases: a multicenter study Cardiopulmonary exercise test among children with congenital heart diseases: a multicenter study Pascal AMEDRO, MD, PhD, Arthur Gavotto, MD, Sophie GUILLAUMONT, MD, Stefan MATECKI, MD, PhD Pediatric and

More information

What are the indications for Tricuspid valve repair during LVAD Implant RANJIT JOHN, MD UNIVERSITY OF MINNESOTA

What are the indications for Tricuspid valve repair during LVAD Implant RANJIT JOHN, MD UNIVERSITY OF MINNESOTA What are the indications for Tricuspid valve repair during LVAD Implant RANJIT JOHN, MD UNIVERSITY OF MINNESOTA Contraindications for LVAD Lack of social support system Nonreversible end organ failure

More information

The Role of Cardiac Rehabilitation. The Role of Cardiac Rehabilitation. in Heart Failure. in Heart Failure. History of Cardiac Rehab.

The Role of Cardiac Rehabilitation. The Role of Cardiac Rehabilitation. in Heart Failure. in Heart Failure. History of Cardiac Rehab. The Role of Cardiac Rehabilitation The Role of Cardiac Rehabilitation in Heart Failure in Heart Failure Kate Traynor RN MS FAACVPR Financial Disclosures No relevant financial relationship exists. History

More information

Contribution of genetics for sudden death risk stratification in dilated cardiomyopathy

Contribution of genetics for sudden death risk stratification in dilated cardiomyopathy Contribution of genetics for sudden death risk stratification in dilated cardiomyopathy Pr Philippe Charron Centre de Référence pour les maladies cardiaques héréditaires (1) Hôpital Ambroise Paré, Boulogne

More information

Ventricular Assist Device: Are Early Interventions Superior? Hamang Patel, MD Section of Cardiomyopathy & Heart Transplantation

Ventricular Assist Device: Are Early Interventions Superior? Hamang Patel, MD Section of Cardiomyopathy & Heart Transplantation Ventricular Assist Device: Are Early Interventions Superior? Hamang Patel, MD Section of Cardiomyopathy & Heart Transplantation Objectives Current rationale behind use of MCS Patient Selection Earlier?

More information

Right Ventricular Failure: Prediction, Prevention and Treatment

Right Ventricular Failure: Prediction, Prevention and Treatment Right Ventricular Failure: Prediction, Prevention and Treatment 3 rd European Training Symposium for Heart Failure Cardiologists and Cardiac Surgeons University Hospital Bern June 24-25, 2016 Disclosures:

More information

The life after myocardial infarction: a long quiet river?

The life after myocardial infarction: a long quiet river? The life after myocardial infarction: a long quiet river? Cardiac rehabilitation: for whom and how? Dr. Barnabas GELLEN MD, PhD, FESC Poitiers JESFC 2018 - Paris Conflicts of interest Speaker honoraria

More information

Device Therapy for Heart Failure

Device Therapy for Heart Failure Device Therapy for Heart Failure Dr. Shelley Zieroth FRCPC Assistant Professor, Cardiology, University of Manitoba Director of Cardiac Transplant and Heart Failure Clinics St Boniface General Hospital,

More information

Mechanical Circulatory Support in the Management of Heart Failure

Mechanical Circulatory Support in the Management of Heart Failure Mechanical Circulatory Support in the Management of Heart Failure Feras Bader, MD, MS, FACC Associate Professor of Medicine Director, Heart Failure and Transplant Cleveland Clinic Abu Dhabi Chairman, Heart

More information

Cardiac arrest in patients with coronary artery disease. Claude LE FEUVRE Institut de Cardiologie Pitié-Salpêtrière

Cardiac arrest in patients with coronary artery disease. Claude LE FEUVRE Institut de Cardiologie Pitié-Salpêtrière Cardiac arrest in patients with coronary artery disease Claude LE FEUVRE Institut de Cardiologie Pitié-Salpêtrière Disclosure Statement of Financial Interest I currently have, or have had over the last

More information

Effect of Pre-LVAD PVR on Heart Transplant Outcome

Effect of Pre-LVAD PVR on Heart Transplant Outcome AATS 2015, VAD/ECMO Session Effect of Pre-LVAD PVR on Heart Transplant Outcome Masaki Tsukashita, MD, PhD, Hiroo Takayama, MD, PhD, Koji Takeda, MD, PhD, Jiho Han, BS, Sowmyashree Sreekanth, BS, Lauren

More information

Tri-City Cardiology Consultants FIFTH ANNUAL SYMPOSIUM

Tri-City Cardiology Consultants FIFTH ANNUAL SYMPOSIUM Tri-City Cardiology Consultants FIFTH ANNUAL SYMPOSIUM Faculty Disclosure Banner Baywood Medical Center -Chief of Staff FIFTH ANNUAL SYMPOSIUM NYHA class III-IV symptoms Clinical signs of fluid retention

More information

I have nothing to disclose.

I have nothing to disclose. I have nothing to disclose. Right ventricular failure and need for biventricular support Friedrich Wilhelm Mohr, MD, PhD Munich, August 27, 2012 Male; date of birth: 19.07.1984 Out clinic visit 10/ 2004:

More information

The Role of Exercise in Management of Patients with Heart Failure

The Role of Exercise in Management of Patients with Heart Failure The Role of Exercise in Management of Patients with Heart Failure Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA Chair, ACC Prevention of Cardiovascular Disease Leadership Council and Section Director,

More information

Heart Failure Medical and Surgical Treatment

Heart Failure Medical and Surgical Treatment Heart Failure Medical and Surgical Treatment Daniel S. Yip, M.D. Medical Director, Heart Failure and Transplantation Mayo Clinic Second Annual Lakeland Regional Health Cardiovascular Symposium February

More information

Update on Mechanical Circulatory Support. AATS May 5, 2010 Toronto, ON Canada

Update on Mechanical Circulatory Support. AATS May 5, 2010 Toronto, ON Canada Update on Mechanical Circulatory Support AATS May 5, 2010 Toronto, ON Canada Disclosures NONE Emergency Circulatory Support ECMO Tandem Heart Impella Assessment Cardiac Function Pulmonary function Valvular

More information

Catheter Based Denervation for Heart Failure

Catheter Based Denervation for Heart Failure Catheter Based Denervation for Heart Failure David E. Kandzari, MD, FACC, FSCAI Chief Scientific Officer Director, Interventional Cardiology Piedmont Heart Institute Atlanta, Georgia david.kandzari@piedmont.org

More information

Management of Heart Failure in Adult with Congenital Heart Disease

Management of Heart Failure in Adult with Congenital Heart Disease Management of Heart Failure in Adult with Congenital Heart Disease Ahmed Krimly Interventional and ACHD consultant King Faisal Cardiac Center National Guard Jeddah Background 0.4% of adults have some form

More information

Concomitant Aortic Valve Procedures in Patients Undergoing Implantation of Continuous-Flow LVADs: An INTERMACS Database Analysis

Concomitant Aortic Valve Procedures in Patients Undergoing Implantation of Continuous-Flow LVADs: An INTERMACS Database Analysis Concomitant Aortic Valve Procedures in Patients Undergoing Implantation of Continuous-Flow LVADs: An INTERMACS Database Analysis April 11, 2014 Jason O. Robertson, M.D., M.S.; David C. Naftel, Ph.D., Sunil

More information

Advances in Advanced Heart Failure Therapies. Disclosures. Management Algorithm for Patients in Cardiogenic Shock

Advances in Advanced Heart Failure Therapies. Disclosures. Management Algorithm for Patients in Cardiogenic Shock Advances in Advanced Heart Failure Therapies 9 th Annual Dartmouth Conference on Advances in Heart Failure Therapies Dartmouth-Hitchcock Medical Center May 20, 2013 Joseph G. Rogers, M.D. Associate Professor

More information

Surgery and device intervention for the elderly with heart failure: assessing the need. Devices and Technology for heart failure in 2011

Surgery and device intervention for the elderly with heart failure: assessing the need. Devices and Technology for heart failure in 2011 Surgery and device intervention for the elderly with heart failure: assessing the need Devices and Technology for heart failure in 2011 Assessing cardiovascular function / prognosis (in the elderly): composite

More information

Translating Device and Mechanical Support Guidelines to ACHD Research. Timothy M. Maul, CCP, PhD Perfusionist Sr. Research Scientist

Translating Device and Mechanical Support Guidelines to ACHD Research. Timothy M. Maul, CCP, PhD Perfusionist Sr. Research Scientist Translating Device and Mechanical Support Guidelines to ACHD Research Timothy M. Maul, CCP, PhD Perfusionist Sr. Research Scientist Disclosures No financial disclosures May discuss off-label or investigational

More information

LVADs as a long term or destination therapy for the advanced heart failure

LVADs as a long term or destination therapy for the advanced heart failure LVADs as a long term or destination therapy for the advanced heart failure Prof. Davor Miličić, MD, PhD University of Zagreb School of Medicine Department of Cardiovascular Diseases University Hospital

More information

Damien Logeart. Disclosure: none

Damien Logeart. Disclosure: none Damien Logeart Disclosure: none 13/1/211 HEART FAILURE AND MYOCARDIOPATHIES Best of 21 Damien Logeart Hôpital Lariboisière, Paris Service Cardiologie INSERM U942 Cliquez pour modifier le style des sous-titres

More information

DECLARATION OF CONFLICT OF INTEREST

DECLARATION OF CONFLICT OF INTEREST DECLARATION OF CONFLICT OF INTEREST Cardiogenic Shock Mechanical Support Eulàlia Roig FESC Heart Failure and HT Unit Hospital Sant Pau - UAB Barcelona. Spain No conflics of interest Mechanical Circulatory

More information

The Who, How and When of Advanced Heart Failure Therapies. Disclosures. What is Advanced Heart Failure?

The Who, How and When of Advanced Heart Failure Therapies. Disclosures. What is Advanced Heart Failure? The Who, How and When of Advanced Heart Failure Therapies 9 th Annual Dartmouth Conference on Advances in Heart Failure Therapies Dartmouth-Hitchcock Medical Center Lebanon, NH May 20, 2013 Joseph G. Rogers,

More information

How do Readmissions Impact Survival among Patients with Continuous-Flow Left Ventricular Assist Devices? Findings from INTERMACS

How do Readmissions Impact Survival among Patients with Continuous-Flow Left Ventricular Assist Devices? Findings from INTERMACS How do Readmissions Impact Survival among Patients with Continuous-Flow Left Ventricular Assist Devices? Findings from INTERMACS Rey P. Vivo, MD 1 ; Selim R. Krim, MD 2 ; Jerry D. Estep, MD 3 ; Wissam

More information

UNIVERSITY OF UTAH HEALTH CARE HOSPITALS AND CLINICS

UNIVERSITY OF UTAH HEALTH CARE HOSPITALS AND CLINICS UNIVERSITY OF UTAH HEALTH CARE HOSPITALS AND CLINICS CARDIAC MECHANICAL SUPPORT PROGRAM GUIDELINES CARDIAC MECHANICAL SUPPORT: LVAD BASICS FREQUENT SCENARIOS AND TROUBLESHOOTING Review Date: July 2011

More information

Ventricular Assisting Devices in the Cathlab. Unrestricted

Ventricular Assisting Devices in the Cathlab. Unrestricted Ventricular Assisting Devices in the Cathlab Unrestricted What is a VAD? A single system device that is surgically attached to the left ventricle of the heart and to the aorta for left ventricular support

More information

Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: the EUROMACS-RHF Risk Score Osama I.I. Soliman, MD, PhD, FACC,

More information

CHRONIC HEART FAILURE : WHAT ELSE COULD WE OFFER TO OUR PATIENTS? Cardiac Rehabilitation Society of Thailand

CHRONIC HEART FAILURE : WHAT ELSE COULD WE OFFER TO OUR PATIENTS? Cardiac Rehabilitation Society of Thailand CHRONIC HEART FAILURE : WHAT ELSE COULD WE OFFER TO OUR PATIENTS? Cardiac Rehabilitation Society of Thailand ENHANCED EXTERNAL COUNTER PULSATION Piyanuj Ruckpanich, MD. Cardiac Rehabilitation Center Perfect

More information

Artificial Heart Program

Artificial Heart Program Artificial Heart Program Provider Review: General VAD Overview Indications for VAD Bridge to transplant (BTT) historically most common (~80%) allow rehab from severe CHF while awaiting donor Bridge to

More information

ECMO as a Bridge to Heart Transplant in the Era of LVAD s.

ECMO as a Bridge to Heart Transplant in the Era of LVAD s. Christian Bermudez MD. Associate Professor Director Thoracic Transplantation Division Cardiac Surgery Department of Surgery University of Pennsylvania ECMO as a Bridge to Heart Transplant in the Era of

More information

Do we really need an Artificial Heart? No!! John V. Conte, MD, Professor of Surgery Johns Hopkins University School of Medicine

Do we really need an Artificial Heart? No!! John V. Conte, MD, Professor of Surgery Johns Hopkins University School of Medicine Do we really need an Artificial Heart? No!! John V. Conte, MD, Professor of Surgery Johns Hopkins University School of Medicine Division of Cardiac Surgery The Johns Hopkins Medical Institutions Conflict

More information

Andrew Civitello MD, FACC

Andrew Civitello MD, FACC Timing the Transition from Short Term to Long Term Mechanical Circulatory Support Andrew Civitello MD, FACC Medical Director, Heart Transplant Program Director, Fellowship Co-Director, Baylor St. Luke's

More information

Mechanical Cardiac Support in Acute Heart Failure. Michael Felker, MD, MHS Associate Professor of Medicine Director of Heart Failure Research

Mechanical Cardiac Support in Acute Heart Failure. Michael Felker, MD, MHS Associate Professor of Medicine Director of Heart Failure Research Mechanical Cardiac Support in Acute Heart Failure Michael Felker, MD, MHS Associate Professor of Medicine Director of Heart Failure Research Disclosures Research Support and/or Consulting NHLBI Amgen Cytokinetics

More information

Cardiac rehabilitation: a beneficial effect in CHD?

Cardiac rehabilitation: a beneficial effect in CHD? Cardiac rehabilitation: a beneficial effect in CHD? An Van Berendoncks Department of Cardiology Antwerp University Hospital Outline Why exercise training in CHD? Risk and benefits? Feasibility? Why should

More information

Facts. STRONG Risk Factors for HF* LVAD, BiVAD, RVAD, HVAD 10/21/ million adults in the US have heart failure.

Facts. STRONG Risk Factors for HF* LVAD, BiVAD, RVAD, HVAD 10/21/ million adults in the US have heart failure. 10/21/18 1 Facts 5.8 million adults in the US have heart failure. About ½ of those who have HF have a 5 year life expectancy. STRONG Risk Factors for HF* Coronary Heart Disease/MI/Afib COPD Renal Failure

More information

EMS: Care of the VAD Patient. Brittany Butzler BSN RN VAD Coordinator Froedtert and the Medical College of WI

EMS: Care of the VAD Patient. Brittany Butzler BSN RN VAD Coordinator Froedtert and the Medical College of WI EMS: Care of the VAD Patient Brittany Butzler BSN RN VAD Coordinator Froedtert and the Medical College of WI Disclosure No relevant financial relationships by planners or presenters Left Ventricular Assist

More information

Understanding the Pediatric Ventricular Assist Device

Understanding the Pediatric Ventricular Assist Device Understanding the Pediatric Ventricular Assist Device W. James Parks, MSc., MD Pediatric Cardiologist Assistant Professor of Pediatrics and Radiology Children s Healthcare of Atlanta Sibley Heart Center

More information

Cardiopulmonary Exercise Testing Cases

Cardiopulmonary Exercise Testing Cases Canadian Respiratory Conference - 217 Cardiopulmonary Exercise Testing Cases Darcy D Marciniuk, MD FRCPC FCCP Associate Vice-President Research, University of Saskatchewan Professor, Respirology, Critical

More information

Surgical Options for Advanced Heart Failure

Surgical Options for Advanced Heart Failure Surgical Options for Advanced Heart Failure Benjamin Medalion, MD Director, Transplantation and Heart Failure Surgery Department of Cardiothoracic Surgery Rabin Medical Center, Beilinson Hospital Heart

More information

Why Children Are Not Small Adults? Treatment of Pediatric Patients Needing Mechanical Circulatory Support

Why Children Are Not Small Adults? Treatment of Pediatric Patients Needing Mechanical Circulatory Support Why Children Are Not Small Adults? Treatment of Pediatric Patients Needing Mechanical Circulatory Support Utpal S Bhalala, MD, FAAP Assistant Professor and Director of Research Pediatric Critical Care

More information

Chapter 12. Methods for Aerobic Training and Physiologic Responses

Chapter 12. Methods for Aerobic Training and Physiologic Responses Chapter 12 Methods for Aerobic Training and Physiologic Responses Aerobic Performance Purpose of training Improve performance General principles of physical conditioning Specificity Overload Aerobic Performance

More information

TRANSCATHETER MITRAL VALVE IMPLANTATION FOR SEVERE MITRAL REGURGITATION: THE TENDYNE GLOBAL FEASIBILITY TRIAL 1 YEAR OUTCOMES

TRANSCATHETER MITRAL VALVE IMPLANTATION FOR SEVERE MITRAL REGURGITATION: THE TENDYNE GLOBAL FEASIBILITY TRIAL 1 YEAR OUTCOMES TRANSCATHETER MITRAL VALVE IMPLANTATION FOR SEVERE MITRAL REGURGITATION: THE TENDYNE GLOBAL FEASIBILITY TRIAL 1 YEAR OUTCOMES David WM Muller, MBBS, MD St Vincent s Hospital, Sydney On behalf of the Tendyne

More information

Mechanical assist patient selection, device selection, and outcomes

Mechanical assist patient selection, device selection, and outcomes Mechanical assist patient selection, device selection, and outcomes Josef Stehlik, MD, MPH Associate Professor of Medicine Medical Director, Heart Transplant Program University of Utah School of Medicine

More information

Evaluation of the Right Ventricle in Candidates for Right Ventricular Assist Device Implantation.

Evaluation of the Right Ventricle in Candidates for Right Ventricular Assist Device Implantation. Evaluation of the Right Ventricle in Candidates for Right Ventricular Assist Device Implantation. Evaluation of RVAD Function. Ioannis A Paraskevaidis Attikon University Hospital Historical Perspective

More information

WHEN TO REFER FOR ADVANCED HEART FAILURE THERAPIES

WHEN TO REFER FOR ADVANCED HEART FAILURE THERAPIES WHEN TO REFER FOR ADVANCED HEART FAILURE THERAPIES Mrudula R Munagala, M.D., FACC CO- Director Heart Failure & Circulatory Support Program OklahomaHeart.com Heart Failure Prevalence Heart Failure affects

More information

CLINCIAL APPLICATION OF GUIDELINES IN HEART FAILURE

CLINCIAL APPLICATION OF GUIDELINES IN HEART FAILURE CLINCIAL APPLICATION OF GUIDELINES IN HEART FAILURE SSC Journée d Automne 25 novembre 2010 Dr. Charles Seydoux, spéc. FMH en médecine interne et en cardiologie, Lausanne Dr. Claudia Bösch, Oberärztin Herzinsuffizienz

More information

Peripheral Contributions to HFpEF

Peripheral Contributions to HFpEF Peripheral Contributions to HFpEF Greg Lewis MD Heart Failure Section Head MGH Cardiology Division and Pulmonary Critical Care Unit Harvard Medical School March 12, 2018 Pathophysiology of HFpEF vs. HFrEF

More information

The Pathophysiology of Cardiogenic Shock Knowledge Gaps & Opportunities

The Pathophysiology of Cardiogenic Shock Knowledge Gaps & Opportunities The Pathophysiology of Cardiogenic Shock Knowledge Gaps & Opportunities Navin K. Kapur, MD, FACC, FSCAI, FAHA Associate Professor, Department of Medicine Interventional Cardiology & Advanced Heart Failure

More information

Case - Advanced HF and Shock (INTERMACS 1)

Case - Advanced HF and Shock (INTERMACS 1) Case - Advanced HF and Shock (INTERMACS 1) Navin K. Kapur, MD, FACC, FSCAI, FAHA Associate Professor, Department of Medicine Interventional Cardiology & Advanced Heart Failure Programs Executive Director,

More information

THE USE of VENTRICULAR ASSIST DEVICES in CHILDREN: CURRENT OPTIONS & FUTURE TRENDS

THE USE of VENTRICULAR ASSIST DEVICES in CHILDREN: CURRENT OPTIONS & FUTURE TRENDS THE USE of VENTRICULAR ASSIST DEVICES in CHILDREN: CURRENT OPTIONS & FUTURE TRENDS ADULTS : VAD Better Accepted Technically easier Fewer anatomical constraints HTx is realistic possibility Overall experience

More information

Echo assessment of patients with an ECMO device

Echo assessment of patients with an ECMO device Echo assessment of patients with an ECMO device Evangelos Leontiadis Cardiologist 1st Cardiology Dept. Onassis Cardiac Surgery Center Athens, Greece Gibbon HLM 1953 Goldstein DJ et al, NEJM 1998; 339:1522

More information

Outpatient Treatment of MCS Patient. F. Bennett Pearce, MD Professor of Pediatrics Med Director Heart Transplant COA

Outpatient Treatment of MCS Patient. F. Bennett Pearce, MD Professor of Pediatrics Med Director Heart Transplant COA Outpatient Treatment of MCS Patient F. Bennett Pearce, MD Professor of Pediatrics Med Director Heart Transplant COA Disclosure Statement I DO NOT HAVE ANY RELEVANT FINANCIAL RELATIONSHIPS WITH ANY COMMERCIAL

More information

Further devices to treat heart failure

Further devices to treat heart failure Postgraduate Course Heart Failure Further devices to treat heart failure Pr. Matthias Kirsch Department of Cardiac Surgery Centre Hospitalo-Universitaire Vaudois Université de Lausanne e-mail: matthias.kirsch@chuv.ch

More information

When to implant VAD in patients with heart transplantation indication. Aldo Cannata Dept of Cardiac Surgery Niguarda Ca Granda Hospital Milano

When to implant VAD in patients with heart transplantation indication. Aldo Cannata Dept of Cardiac Surgery Niguarda Ca Granda Hospital Milano When to implant VAD in patients with heart transplantation indication Aldo Cannata Dept of Cardiac Surgery Niguarda Ca Granda Hospital Milano LVAD strategies In waiting list? Goal Bridge to transplant

More information

Laura McGarrigle MSc MCSP Clinical Specialist Physiotherapist

Laura McGarrigle MSc MCSP Clinical Specialist Physiotherapist Cardiac Rehabilitation and Completion after Left Ventricular Assist Device (LVAD) implantation: The impact of education for local cardiac rehabilitation teams. Laura McGarrigle MSc MCSP Clinical Specialist

More information

Acute heart failure, beyond conventional treatment: persisting low output

Acute heart failure, beyond conventional treatment: persisting low output Acute heart failure, beyond conventional treatment: persisting low output Alexandre Mebazaa, FESC Hôpital Lariboisière, Université Paris 7 U942 Inserm Conflict of Interest Lecture fee: Orion No other conflicts

More information

"Acute cardiovascular responses to different types of exercise and in different populations"

Acute cardiovascular responses to different types of exercise and in different populations "Acute cardiovascular responses to different types of exercise and in different populations" Dott. Anna Baraldo Phd Course In Science of Physical Exercise and Human Movement - 24 Department of Neurological

More information

Evaluation of Native Left Ventricular Function During Mechanical Circulatory Support.: Theoretical Basis and Clinical Limitations

Evaluation of Native Left Ventricular Function During Mechanical Circulatory Support.: Theoretical Basis and Clinical Limitations Review Evaluation of Native Left Ventricular Function During Mechanical Circulatory Support.: Theoretical Basis and Clinical Limitations Tohru Sakamoto, MD, PhD Left ventricular function on patients with

More information

Optimizing the Lung Transplant Candidate through Exercise Training. Lisa Wickerson BScPT, MSc Canadian Respiratory Conference April 25, 2014

Optimizing the Lung Transplant Candidate through Exercise Training. Lisa Wickerson BScPT, MSc Canadian Respiratory Conference April 25, 2014 Optimizing the Lung Transplant Candidate through Exercise Training Lisa Wickerson BScPT, MSc Canadian Respiratory Conference April 25, 2014 Conflicts of Interest None to declare Learning Objectives At

More information

Ivana Nedeljkovic, M Ostojic, V Giga, V Stojanov, J Stepanovic, A Djordjevic Dikic, B Beleslin, M Nikolic, M Petrovic, D Popovic

Ivana Nedeljkovic, M Ostojic, V Giga, V Stojanov, J Stepanovic, A Djordjevic Dikic, B Beleslin, M Nikolic, M Petrovic, D Popovic Combined cardiopulmonary exercise stress echocardiography test: New test for assessment of diastolic dysfunction in patients with hypertension Ivana Nedeljkovic, M Ostojic, V Giga, V Stojanov, J Stepanovic,

More information

Candidate Selection for Long Term VAD

Candidate Selection for Long Term VAD 6th Saudi Heart Failure Symposium Riyadh - December 9, 2017 Candidate Selection for Long Term VAD AMMAR CHAUDHARY, MBCHB, FRCPC Consultant Cardiologist Advanced Heart Failure Department of Cardiology King

More information

Mechanical Circulatory Support (MCS): What Every Pharmacist Needs to Know!

Mechanical Circulatory Support (MCS): What Every Pharmacist Needs to Know! Mechanical Circulatory Support (MCS): What Every Pharmacist Needs to Know! Matthew A. Wanat, PharmD, BCPS, BCCCP, FCCM Clinical Assistant Professor University of Houston College of Pharmacy Clinical Pharmacy

More information

Mechanical circulatory support in cardiogenic shock The Cardiologist s view ACCA Masterclass 2017

Mechanical circulatory support in cardiogenic shock The Cardiologist s view ACCA Masterclass 2017 Mechanical circulatory support in cardiogenic shock The Cardiologist s view ACCA Masterclass 2017 Pascal Vranckx MD, PhD. Medical director Cardiac Critical Care Services Hartcentrum Hasselt Belgium Disclosure

More information

CPX and Prognosis in Cardiovascular Disease

CPX and Prognosis in Cardiovascular Disease CPX and Prognosis in Cardiovascular Disease Anselm K. Gitt, Piergiuseppe Agostoni Herzzentrum Ludwigshafen, Germany Instituto di Cardiologia Università di Milano, Milan, Italy Cardiopulmonary exercise

More information

Management of Acute Shock and Right Ventricular Failure

Management of Acute Shock and Right Ventricular Failure Management of Acute Shock and Right Ventricular Failure Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic NONE Disclosures CARDIOGENIC SHOCK

More information

When is it too late to perform transcatheter mitral valve repair? Alec Vahanian, FESC,FRCP(Edin.) Bichat hospital University Paris VII

When is it too late to perform transcatheter mitral valve repair? Alec Vahanian, FESC,FRCP(Edin.) Bichat hospital University Paris VII When is it too late to perform transcatheter mitral valve repair? Alec Vahanian, FESC,FRCP(Edin.) Bichat hospital University Paris VII I, (Alec Vahanian) DO have a financial interest/arrangement or affiliation

More information

AllinaHealthSystem 1

AllinaHealthSystem 1 : Definition End-organ hypoperfusion secondary to cardiac failure Venoarterial ECMO: Patient Selection Michael A. Samara, MD FACC Advanced Heart Failure, Cardiac Transplant & Mechanical Circulatory Support

More information

RED CELL DISTRIBUTION WIDTH

RED CELL DISTRIBUTION WIDTH RED CELL DISTRIBUTION WIDTH A NEW MARKER OF EXERCISE INTOLERANCE IN PATIENTS WITH CHRONIC HEART FAILURE Emeline Van Craenenbroeck, Paul Beckers, Nadine Possemiers, Christiaan Vrints, Viviane Conraads Cardiology

More information

The right heart: the Cinderella of heart failure

The right heart: the Cinderella of heart failure The right heart: the Cinderella of heart failure Piotr Ponikowski, MD, PhD, FESC Medical University, Centre for Heart Disease Clinical Military Hospital Wroclaw, Poland none Disclosure Look into the Heart

More information

Assist Devices in STEMI- Intra-aortic Balloon Pump

Assist Devices in STEMI- Intra-aortic Balloon Pump Assist Devices in STEMI- Intra-aortic Balloon Pump Ioannis Iakovou, MD, PhD Onassis Cardiac Surgery Center Athens, Greece Cardiogenic shock 5-10% of pts after a heart attack 60000-70000 pts in Europe/year

More information